Foreign GMP inspection to be expanded, KFDA officials say

The Korea Food and Drug Administration will strengthen its on-spot inspection on foreign GMP facilities as part of efforts to ensure the quality of medicinal products.

So far, the KFDA has conducted its on-spot inspections on GMP facilities of Merck, Pfizer and Schwarz Pharma, saying Merck’s Isentress, first-in-class oral HIV-1 integrase Inhibitor, was approved on June 23.

“The foreign on...